{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T17:29:32Z","timestamp":1794590972435,"version":"4.9.1"},"reference-count":435,"publisher":"Elsevier BV","issue":"7-8","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.neuropharm.2010.10.022","type":"journal-article","created":{"date-parts":[[2010,10,30]],"date-time":"2010-10-30T04:31:57Z","timestamp":1288413117000},"page":"1017-1041","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":626,"title":["Metabotropic glutamate receptors: From the workbench to the bedside"],"prefix":"10.1016","volume":"60","author":[{"given":"F.","family":"Nicoletti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Bockaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.L.","family":"Collingridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.J.","family":"Conn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Ferraguti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.D.","family":"Schoepp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.T.","family":"Wroblewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.P.","family":"Pin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2010.10.022_bib1","doi-asserted-by":"crossref","first-page":"13361","DOI":"10.1016\/S0021-9258(18)42219-3","article-title":"Molecular characterization of a novel metabotropic glutamate receptor mGluR5 coupled to inositol phosphate\/Ca2+ signal transduction","volume":"267","author":"Abe","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib2","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrn2356","article-title":"Metaplasticity: tuning synapses and networks for plasticity","volume":"9","author":"Abraham","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib3","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1124\/jpet.106.105387","article-title":"Pharmacological stimulation of group II metabotropic glutamate receptors reduces cocaine self-administration and cocaine-induced reinstatement of drug seeking in squirrel monkeys","volume":"318","author":"Adewale","year":"2006","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib4","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0006-8993(99)01224-X","article-title":"Serotonin, via 5-HT2A receptors, increases EPSCs in layer V pyramidal cells of prefrontal cortex by an asynchronous mode of glutamate release","volume":"825","author":"Aghajanian","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib5","doi-asserted-by":"crossref","first-page":"6689","DOI":"10.1523\/JNEUROSCI.4453-09.2010","article-title":"IP3 receptor sensitization during in vivo amphetamine experience enhances NMDA receptor plasticity in dopamine neurons of the ventral tegmental area","volume":"30","author":"Ahn","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib6","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0092-8674(94)90204-6","article-title":"Reduced hippocampal long-term potentiation and context-specific deficit in associative learning in mGluR1 mutant mice","volume":"79","author":"Aiba","year":"1994","journal-title":"Cell"},{"issue":"Suppl. 1","key":"10.1016\/j.neuropharm.2010.10.022_bib7","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.neuropharm.2005.05.005","article-title":"NMDA-induced potentiation of mGluR5 is mediated by activation of protein phosphatase 2B\/calcineurin","volume":"49","author":"Alagarsamy","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib8","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.neuroscience.2008.07.045","article-title":"A specific role for group II metabotropic glutamate receptors in hippocampal long-term depression and spatial memory","volume":"158","author":"Altinbilek","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.brainresbull.2010.01.011","article-title":"Effects of early and delayed treatment with an mGluR5 antagonist on motor impairment, nigrostriatal damage and neuroinflammation in a rodent model of Parkinson\u2019s disease","volume":"82","author":"Ambrosi","year":"2010","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib10","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.bbr.2010.01.021","article-title":"Influence of amygdaloid glutamatergic receptors on sensory and emotional pain-related behavior in the neuropathic rat","volume":"209","author":"Ansah","year":"2010","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib11","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.expneurol.2008.11.005","article-title":"Enhanced pronociception by amygdaloid group I metabotropic glutamate receptors in nerve-injured animals","volume":"216","author":"Ansah","year":"2009","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib12","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1215\/S1152851704000961","article-title":"Pharmacological blockade of group II metabotropic glutamate receptors reduces the growth of glioma cells in vivo","volume":"7","author":"Arcella","year":"2005","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib13","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1046\/j.1460-9568.2000.00131.x","article-title":"Upregulation of metabotropic glutamate receptor subtype mGluR3 and mGluR5 in reactive astrocytes in a rat model of mesial temporal lobe epilepsy","volume":"12","author":"Aronica","year":"2000","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib14","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1046\/j.1528-1157.2003.54802.x","article-title":"Expression and cell distribution of group I and group II metabotropic glutamate receptor subtypes in taylor-type focal cortical dysplasia","volume":"44","author":"Aronica","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib15","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/sj.bjp.0703904","article-title":"Activation of type 5 metabotropic glutamate receptors enhances NMDA responses in mice cortical wedges","volume":"132","author":"Attucci","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib16","doi-asserted-by":"crossref","first-page":"7871","DOI":"10.1523\/JNEUROSCI.20-21-07871.2000","article-title":"Activation of metabotropic glutamate receptor 5 has direct excitatory effects and potentiates NMDA receptor currents in neurons of the subthalamic nucleus","volume":"20","author":"Awad","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib17","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1046\/j.1471-4159.1997.69010151.x","article-title":"Metabotropic glutamate receptor mGluR5 in astrocytes: pharmacological properties and agonist regulation","volume":"69","author":"Bal\u00e1zs","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib18","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s00213-005-2211-9","article-title":"The effect of the mGlu5 receptor antagonist MPEP in rodent tests of anxiety and cognition: a comparison","volume":"179","author":"Ballard","year":"2005","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib19","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1159\/000015551","article-title":"Assignment of the human metabotropic glutamate receptor gene GRM4 to chromosome 6 band p21.3 by radiation hybrid mapping","volume":"88","author":"Barbon","year":"2000","journal-title":"Cytogenet. Cell. Genet."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib20","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1159\/000015541","article-title":"Assignment of the human metabotropic glutamate receptor gene GRM7 to chromosome 3p26.1\u00a0\u2192\u00a0p25.2 by radiation hybrid mapping","volume":"88","author":"Barbon","year":"2000","journal-title":"Cytogenet. Cell. Genet."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib21","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.cell.2009.09.028","article-title":"Cellular and molecular mechanisms of pain","volume":"139","author":"Basbaum","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib22","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/385074a0","article-title":"Frequency detection and temporally dispersed synaptic signal association through a metabotropic glutamate receptor pathway","volume":"385","author":"Batchelor","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib23","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0028-3908(97)00014-2","article-title":"Pharmacological characterization of synaptic transmission through mGluRs in rat cerebellar slices","volume":"36","author":"Batchelor","year":"1997","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib24","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0304-3940(97)00442-4","article-title":"In vivo inhibition of veratridine-evoked release of striatal excitatory amino acids by the group II metabotropic glutamate receptor agonist LY354740 in rats","volume":"229","author":"Battaglia","year":"1997","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib25","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1523\/JNEUROSCI.22-06-02135.2002","article-title":"Selective blockade of mGlu5 metabotropic glutamate receptors is protective against methamphetamine neurotoxicity","volume":"22","author":"Battaglia","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib26","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0028-3908(03)00146-1","article-title":"Protective role of group-II metabotropic glutamate receptors against nigro-striatal degeneration induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice","volume":"45","author":"Battaglia","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib27","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1523\/JNEUROSCI.3831-03.2004","article-title":"Endogenous activation of mGlu5 metabotropic glutamate receptors contributes to the development of nigro-striatal damage induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice","volume":"24","author":"Battaglia","year":"2004","journal-title":"J. Neurosci."},{"issue":"8","key":"10.1016\/j.neuropharm.2010.10.022_bib29","doi-asserted-by":"crossref","first-page":"e6591","DOI":"10.1371\/journal.pone.0006591","article-title":"Activation of mGlu3 receptors stimulates the production of GDNF in striatal neurons","volume":"4","author":"Battaglia","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib30","article-title":"Early defect of transforming growth factor beta-1 formation in Huntington\u2019s disease","author":"Battaglia","year":"2010","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib31","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/0896-6273(93)90086-7","article-title":"The metabotropic glutamate receptor (mGluR1 alpha) is concentrated at perisynaptic membrane of neuronal subpopulations as detected by immunogold reaction","volume":"11","author":"Baude","year":"1993","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib32","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1124\/mol.107.035170","article-title":"A selective positive allosteric modulator of metabotropic glutamate receptor subtype 2 blocks a hallucinogenic drug model of psychosis","volume":"72","author":"Benneyworth","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib33","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1471-4159.2006.04121.x","article-title":"MacMARCKS interacts with the metabotropic glutamate receptor type 7 and modulates G protein-mediated constitutive inhibition of calcium channels","volume":"99","author":"Bertaso","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib34","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/nn.2142","article-title":"PICK1 uncoupling from mGluR7a causes absence-like seizures","volume":"11","author":"Bertaso","year":"2008","journal-title":"Nat. Neurosci."},{"issue":"Suppl. 1","key":"10.1016\/j.neuropharm.2010.10.022_bib35","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.neuropharm.2005.06.007","article-title":"Metabotropic glutamate receptor (mGluR5) antagonist MPEP attenuated cue- and schedule-induced reinstatement of nicotine self-administration behavior in rats","volume":"49","author":"Bespalov","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib36","doi-asserted-by":"crossref","first-page":"11097","DOI":"10.1073\/pnas.162138699","article-title":"Closure of the Venus flytrap module of mGlu8 receptor and the activation process: insights from mutations converting antagonists into agonists","volume":"99","author":"Bessis","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib37","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1096\/fj.09-131789","article-title":"Electrophysiological and behavioral evidence that modulation of metabotropic glutamate receptor 4 with a new agonist reverses experimental parkinsonism","volume":"23","author":"Beurrier","year":"2009","journal-title":"FASEB J."},{"issue":"4","key":"10.1016\/j.neuropharm.2010.10.022_bib38","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/86075","article-title":"Peripheral group I metabotropic glutamate receptors modulate nociception in mice","volume":"2001","author":"Bhave","year":"2001","journal-title":"Nat. Neurosci."},{"issue":"5","key":"10.1016\/j.neuropharm.2010.10.022_bib39","doi-asserted-by":"crossref","first-page":"e2155","DOI":"10.1371\/journal.pone.0002155","article-title":"MGluR5 mediates the interaction between late-LTP, network activity, and learning","volume":"3","author":"Bikbaev","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib40","doi-asserted-by":"crossref","first-page":"12154","DOI":"10.1074\/jbc.M611071200","article-title":"Common structural requirements for heptahelical domain function in class A and class C G protein-coupled receptors","volume":"282","author":"Binet","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib41","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1017\/S1461145709990162","article-title":"Cocaine-mediated synaptic potentiation is absent in VTA neurons from mGlu5-deficient mice","volume":"13","author":"Bird","year":"2010","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib42","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/0306-4522(93)90400-A","article-title":"Phenylglycine derivatives as new pharmacological tools for investigating the role of metabotropic glutamate receptors in the central nervous system","volume":"52","author":"Birse","year":"1993","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib43","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.schres.2005.04.001","article-title":"Association between the polymorphic GRM3 gene and negative symptom improvement during olanzapine treatment","volume":"77","author":"Bishop","year":"2005","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib44","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/YPG.0b013e3281ac231e","article-title":"Association analysis of the metabotropic glutamate receptor type 3 gene (GRM3) with schizophrenia","volume":"17","author":"Bishop","year":"2007","journal-title":"Psychiatr. Genet."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib45","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1528-1167.2005.00311.x","article-title":"Cellular and network mechanisms of spike-wave seizures","volume":"9","author":"Blumenfeld","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib46","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/80624","article-title":"Dual MAP kinase pathways mediate opposing forms of long-term plasticity at CA3-CA1 synapses","volume":"3","author":"Bolshakov","year":"2000","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib47","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/S0022-3565(24)39139-6","article-title":"Neuroprotective effects of LY379268, a selective mGlu2\/3 receptor agonist: investigations into possible mechanism of action in vivo","volume":"294","author":"Bond","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib48","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0304-3940(99)00663-1","article-title":"LY379268, a potent and selective group II metabotropic glutamate receptor agonist, is neuroprotective in gerbil global, but not focal, cerebral ischaemia","volume":"273","author":"Bond","year":"1999","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib49","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.neuropharm.2008.05.020","article-title":"Distinct roles of group I mGlu receptors in striatal function","volume":"55","author":"Bonsi","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib50","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/368740a0","article-title":"A molecular switch activated by metabotropic glutamate receptors regulates induction of long-term potentiation","volume":"368","author":"Bortolotto","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib51","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0028-3908(98)00058-6","article-title":"Involvement of calcium\/calmodulin-dependent protein kinases in the setting of a molecular switch involved in hippocampal LTP","volume":"37","author":"Bortolotto","year":"1998","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib52","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1046\/j.1460-9568.2000.00291.x","article-title":"A role for protein kinase C in a form of metaplasticity that regulates the induction of long-term potentiation at CA1 synapses of the adult rat hippocampus","volume":"12","author":"Bortolotto","year":"2000","journal-title":"Eur. J. Neurosci."},{"issue":"Suppl. 1","key":"10.1016\/j.neuropharm.2010.10.022_bib53","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neuropharm.2005.05.020","article-title":"The regulation of hippocampal LTP by the molecular switch, a form of metaplasticity, requires mGlu5 receptors","volume":"49","author":"Bortolotto","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib54","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.neuropharm.2008.06.020","article-title":"An analysis of the stimulus requirements for setting the molecular switch reveals a lower threshold for metaplasticity than synaptic plasticity","volume":"55","author":"Bortolotto","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib55","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0896-6273(00)00127-6","article-title":"Presynaptic clustering of mGluR7a requires the PICK1 PDZ domain binding site","volume":"28","author":"Boudin","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib56","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1001\/archpsyc.1992.01820030038005","article-title":"Gating and habituation of the startle reflex in schizophrenic patients","volume":"49","author":"Braff","year":"1992","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib57","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/386284a0","article-title":"Homer: a protein that selectively binds metabotropic glutamate receptors","volume":"386","author":"Brakeman","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib58","doi-asserted-by":"crossref","first-page":"8302","DOI":"10.1523\/JNEUROSCI.23-23-08302.2003","article-title":"Metabotropic glutamate 5 receptor blockade alleviates akinesia by normalizing activity of selective basal-ganglia structures in parkinsonian rats","volume":"23","author":"Breysse","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib59","doi-asserted-by":"crossref","first-page":"5669","DOI":"10.1523\/JNEUROSCI.22-13-05669.2002","article-title":"Chronic but not acute treatment with a metabotropic glutamate 5 receptor antagonist reverses the akinetic deficits in a rat model of parkinsonism","volume":"22","author":"Breysse","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib60","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0091-3057(02)00828-6","article-title":"Anxiolytic-like activity of the mGluR5 antagonist MPEP: a comparison with diazepam and buspirone","volume":"73","author":"Brodkin","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib61","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1111\/j.1460-9568.2003.03073.x","article-title":"Disruption of prepulse inhibition in mice lacking mGluR1","volume":"18","author":"Brody","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib62","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/sj.mp.4001404","article-title":"Assessment of a prepulse inhibition deficit in a mutant mouse lacking mGlu5 receptors","volume":"9","author":"Brody","year":"2004","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib63","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1111\/j.1460-9568.1995.tb00712.x","article-title":"Activation of class II or III metabotropic glutamate receptors protects cultured cortical neurons against excitotoxic degeneration","volume":"7","author":"Bruno","year":"1995","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib64","doi-asserted-by":"crossref","first-page":"9594","DOI":"10.1523\/JNEUROSCI.18-23-09594.1998","article-title":"Neuroprotection by glial metabotropic glutamate receptors is mediated by transforming growth factor-beta","volume":"18","author":"Bruno","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib65","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1097\/00004647-200109000-00001","article-title":"Metabotropic glutamate receptor subtypes as targets for neuroprotective drugs","volume":"21","author":"Bruno","year":"2001","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib66","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1038\/sj.npp.1300540","article-title":"The behavioral profile of the potent and selective mGlu5 receptor antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine (MTEP) in rodent models of anxiety","volume":"29","author":"Busse","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib67","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1523\/JNEUROSCI.4956-04.2005","article-title":"Interactions between ephrin-B and metabotropic glutamate 1 receptors in brain tissue and cultured neurons","volume":"25","author":"Cal\u00f2","year":"2005","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1471-4159.2006.03844.x","article-title":"Interaction between ephrins\/Eph receptors and excitatory amino acid receptors: possible relevance in the regulation of synaptic plasticity and in the pathophysiology of neuronal degeneration","volume":"98","author":"Cal\u00f2","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib69","doi-asserted-by":"crossref","first-page":"9301","DOI":"10.1523\/JNEUROSCI.1367-09.2009","article-title":"Retina-specific GTPase accelerator RGS11\/G beta 5S\/R9AP is a constitutive heterotrimer selectively targeted to mGluR6 in ON-bipolar neurons","volume":"29","author":"Cao","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib70","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s00213-004-1827-5","article-title":"The mGluR5 antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) potentiates PCP-induced cognitive deficits in rats","volume":"175","author":"Campbell","year":"2004","journal-title":"Psychopharmacology (Berl.)"},{"issue":"Suppl. 1","key":"10.1016\/j.neuropharm.2010.10.022_bib71","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.neuropharm.2005.05.014","article-title":"Endogenous activation of mGlu5 metabotropic glutamate receptors supports self-renewal of cultured mouse embryonic stem cells","volume":"49","author":"Cappuccio","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib72","article-title":"TGF-beta1 pathway as a new target for neuroprotection in Alzheimer\u2019s disease","author":"Caraci","year":"2009","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib73","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.brainres.2008.10.066","article-title":"Group II metabotropic glutamate receptor activation on peripheral nociceptors modulates TRPV1 function","volume":"1248","author":"Carlton","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib74","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1124\/mol.59.5.965","article-title":"BAY36-7620: a potent non-competitive mGlu1 receptor antagonist with inverse agonist activity","volume":"59","author":"Carroll","year":"2001","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib75","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1460-9568.1997.tb01348.x","article-title":"Expression and coupling to polyphosphoinositide hydrolysis of group I metabotropic glutamate receptors in early postnatal and adult rat brain","volume":"9","author":"Casabona","year":"1997","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib76","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.tins.2007.03.005","article-title":"Dopamine dysregulation of movement control in l-DOPA-induced dyskinesia","volume":"30","author":"Cenci","year":"2007","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib77","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.neuropharm.2003.10.009","article-title":"MGS0039: a potent and selective group II metabotropic glutamate receptor antagonist with antidepressant-like activity","volume":"46","author":"Chaki","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib78","doi-asserted-by":"crossref","first-page":"738S","DOI":"10.3945\/ajcn.2009.27462H","article-title":"Taste receptors for umami: the case for multiple receptors","volume":"90","author":"Chaudhari","year":"2009","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib79","doi-asserted-by":"crossref","first-page":"5403","DOI":"10.1093\/emboj\/cdg528","article-title":"Mechanisms underlying excitatory effects of group I metabotropic glutamate receptors via inhibition of 2P domain K+ channels","volume":"22","author":"Chemin","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib80","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nn0901-873","article-title":"Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice","volume":"4","author":"Chiamulera","year":"2001","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib81","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S0026-895X(24)12194-3","article-title":"l-Acetylcarnitine induces analgesia by selectively up-regulating mGlu2 metabotropic glutamate receptors","volume":"61","author":"Chiechio","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib82","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1744-8069-2-20","article-title":"Transcriptional regulation of metabotropic glutamate receptor 2\/3 expression by the NF-kappaB pathway in primary dorsal root ganglia neurons: a possible mechanism for the analgesic effect of l-acetylcarnitine","volume":"2","author":"Chiechio","year":"2006","journal-title":"Mol. Pain"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib83","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1124\/mol.108.054346","article-title":"Epigenetic modulation of mGlu2 receptors by histone deacetylase inhibitors in the treatment of inflammatory pain","volume":"75","author":"Chiechio","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib84","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.tips.2009.12.003","article-title":"Transcriptional regulation of type-2 metabotropic glutamate receptors: an epigenetic path to novel treatments for chronic pain","volume":"31","author":"Chiechio","year":"2010","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib85","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1523\/JNEUROSCI.16-01-00036.1996","article-title":"Metabotropic glutamate receptor modulation of voltage-gated Ca2+ channels involves multiple receptor subtypes in cortical neurons","volume":"16","author":"Choi","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib86","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1124\/jpet.109.152553","article-title":"The neuroactive peptide N-acetylaspartylglutamate is not an agonist at the metabotropic glutamate receptor subtype 3 of metabotropic glutamate receptor","volume":"330","author":"Chopra","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib87","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/(SICI)1098-1136(199909)27:3<275::AID-GLIA9>3.0.CO;2-0","article-title":"Activation of A(1) adenosine or mGlu3 metabotropic glutamate receptors enhances the release of nerve growth factor and S-100beta protein from cultured astrocytes","volume":"27","author":"Ciccarelli","year":"1999","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib434","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.neuropharm.2008.06.064","article-title":"Type-3 metabotropic glutamate receptors negatively modulate bone morphogenetic protein receptor signaling and support the tumourigenic potential of glioma-initiating cells","volume":"55","author":"Ciceroni","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib88","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.biopsych.2009.12.018","article-title":"Alcohol-induced neurodegeneration, suppression of transforming growth factor-beta, and cognitive impairment in rats: prevention by group II metabotropic glutamate receptor activation","volume":"67","author":"Cippitelli","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib89","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/(SICI)1098-1063(1998)8:2<160::AID-HIPO8>3.0.CO;2-P","article-title":"Priming of long-term potentiation induced by activation of metabotropic glutamate receptors coupled to phospholipase C","volume":"8","author":"Cohen","year":"1998","journal-title":"Hippocampus"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib90","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/sj.bjp.0705861","article-title":"Interactions between NMDA receptors and mGlu5 receptors expressed in HEK293 cells","volume":"142","author":"Collett","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib91","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nrn1763","article-title":"Metabotropic glutamate receptors in the basal ganglia motor circuit","volume":"6","author":"Conn","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib92","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1124\/mi.8.2.7","article-title":"Schizophrenia: moving beyond monoamine antagonists","volume":"8","author":"Conn","year":"2008","journal-title":"Mol. Interv."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib93","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.tips.2008.10.006","article-title":"Activation of metabotropic glutamate receptors as a novel approach for the treatment of schizophrenia","volume":"30","author":"Conn","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib94","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/372237a0","article-title":"Motor deficit and impairment of synaptic plasticity in mice lacking mGluR1","volume":"372","author":"Conquet","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib95","first-page":"593","article-title":"crv4, a mouse model for human ataxia associated with kyphoscoliosis caused by an mRNA splicing mutation of the metabotropic glutamate receptor 1 (Grm1)","volume":"18","author":"Conti","year":"2006","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib96","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0026-895X(25)08600-6","article-title":"Activation of metabotropic glutamate receptors protects cultured neurons against apoptosis induced by beta-amyloid peptide","volume":"47","author":"Copani","year":"1995","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib97","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1046\/j.1460-9568.1998.00371.x","article-title":"Cloning and characterization of alternative mRNA forms for the rat metabotropic glutamate receptors mGluR7 and mGluR8","volume":"10","author":"Corti","year":"1998","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib98","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3109\/01677060009084499","article-title":"Genomic organization of the human metabotropic glutamate receptor subtype 3","volume":"14","author":"Corti","year":"2000","journal-title":"J.\u00a0Neurogenet."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib99","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.biopsych.2006.12.005","article-title":"Altered dimerization of metabotropic glutamate receptor 3 in schizophrenia","volume":"62","author":"Corti","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib100","doi-asserted-by":"crossref","first-page":"8297","DOI":"10.1523\/JNEUROSCI.1889-07.2007","article-title":"The use of knock-out mice unravels distinct roles for mGlu2 and mGlu3 metabotropic glutamate receptors in mechanisms of neurodegeneration\/neuroprotection","volume":"27","author":"Corti","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib101","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1113\/jphysiol.1986.sp016227","article-title":"Effects of excitatory amino acid antagonists on evoked and spontaneous excitatory potentials in guinea-pig hippocampus","volume":"378","author":"Cotman","year":"1986","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib102","doi-asserted-by":"crossref","first-page":"38213","DOI":"10.1074\/jbc.M006075200","article-title":"G protein-coupled receptor kinase-mediated desensitization of metabotropic glutamate receptor 1A protects against cell death","volume":"275","author":"Dale","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib103","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.neuropharm.2003.10.014","article-title":"Blockade of glutamate mGlu5 receptors in a rat model of neuropathic pain prevents early over-expression of pro-apoptotic genes and morphological changes in dorsal horn lamina II","volume":"46","author":"de Novellis","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib104","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.neuroscience.2005.03.014","article-title":"Periaqueductal grey CB1 cannabinoid and metabotropic glutamate subtype 5 receptors modulate changes in rostral ventromedial medulla neuronal activities induced by subcutaneous formalin in the rat","volume":"134","author":"de Novellis","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib105","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S0026-895X(25)10517-8","article-title":"Cloning and expression of a human metabotropic glutamate receptor 1 alpha: enhanced coupling on co-transfection with a glutamate transporter","volume":"48","author":"Desai","year":"1995","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib106","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/sj.mp.4000848","article-title":"The genomic organisation of the metabotropic glutamate receptor subtype 5 gene, and its association with schizophrenia","volume":"6","author":"Devon","year":"2001","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib107","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.nbd.2008.04.002","article-title":"Rescue of behavioral phenotype and neuronal protrusion morphology in Fmr1 KO mice","volume":"31","author":"de Vrij","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib108","doi-asserted-by":"crossref","first-page":"5684","DOI":"10.1523\/JNEUROSCI.0492-04.2004","article-title":"A retinal-specific regulator of G-protein signaling interacts with Galpha(o) and accelerates an expressed metabotropic glutamate receptor 6 cascade","volume":"24","author":"Dhingra","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib109","doi-asserted-by":"crossref","first-page":"5274","DOI":"10.1073\/pnas.85.14.5274","article-title":"Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats","volume":"85","author":"Di Chiara","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib110","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1038\/sj.cdd.4401639","article-title":"Endogenous activation of metabotropic glutamate receptors supports the proliferation and survival of neural progenitor cells","volume":"12","author":"Di Giorgi-Gerevini","year":"2005","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib111","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.neuroscience.2009.11.012","article-title":"Group II metabotropic glutamate receptor activation by agonist LY379268 treatment increases the expression of brain derived neurotrophic factor in the mouse brain","volume":"165","author":"Di Liberto","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib112","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0028-3908(97)00001-4","article-title":"(RS)-2-Chloro-5-hydroxyphenylglycine (CHPG) activates mGlu5, but no mGlu1, receptors expressed in CHO cells and potentiates NMDA responses in the hippocampus","volume":"36","author":"Doherty","year":"1997","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib113","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.neuron.2007.12.001","article-title":"Correction of fragile X syndrome in mice","volume":"56","author":"D\u00f6len","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib114","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1113\/jphysiol.2008.150722","article-title":"Role for metabotropic glutamate receptor 5 (mGluR5) in the pathogenesis of fragile X syndrome","volume":"586","author":"D\u00f6len","year":"2008","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib115","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1046\/j.1471-4159.2001.00435.x","article-title":"Neuroprotection mediated by glial group-II metabotropic glutamate receptors requires the activation of the MAP kinase and the phosphatidylinositol-3-kinase pathways","volume":"78","author":"D\u2019Onofrio","year":"2001","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib116","first-page":"1","article-title":"A new approach to analyze cell surface protein complexes reveals specific heterodimeric metabotropic glutamate receptors","volume":"25","author":"Doumazane","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib117","doi-asserted-by":"crossref","first-page":"4884","DOI":"10.1073\/pnas.0501233102","article-title":"Night blindness and abnormal cone electroretinogram ON responses in patients with mutations in the GRM6 gene encoding mGluR6","volume":"102","author":"Dryja","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib118","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1038\/sj.npp.1301531","article-title":"Efficacy and tolerability of an mGlu2\/3 agonist in the treatment of generalized anxiety disorder","volume":"33","author":"Dunayevich","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib119","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1523\/JNEUROSCI.15-04-03075.1995","article-title":"A novel metabotropic glutamate receptor expressed in the retina and olfactory bulb","volume":"15","author":"Duvoisin","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib120","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1460-9568.2005.04210.x","article-title":"Increased measures of anxiety and weight gain in mice lacking the group III metabotropic glutamate receptor mGluR8","volume":"22","author":"Duvoisin","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib121","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.bbr.2010.04.006","article-title":"Acute pharmacological modulation of mGluR8 reduces measures of anxiety","volume":"212","author":"Duvoisin","year":"2010","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib122","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0922-4106(93)90028-8","article-title":"Competitive antagonism at metabotropic glutamate receptors by (S)-4-carboxyphenylglycine and (RS)-alpha-methyl-4-carboxyphenylglycine","volume":"244","author":"Eaton","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib123","doi-asserted-by":"crossref","first-page":"12604","DOI":"10.1073\/pnas.0405077101","article-title":"Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia","volume":"101","author":"Egan","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib124","doi-asserted-by":"crossref","first-page":"30662","DOI":"10.1074\/jbc.M102573200","article-title":"Mapping of calmodulin and Gbetagamma binding domains within the C-terminal region of the metabotropic glutamate receptor 7A","volume":"276","author":"El Far","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib125","doi-asserted-by":"crossref","first-page":"26041","DOI":"10.1074\/jbc.M110.139899","article-title":"The protective signaling of metabotropic glutamate receptor 1 is mediated by sustained, \u03b2-arrestin-1-dependent ERK phosphorylation","volume":"285","author":"Emery","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib126","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/0028-3908(96)84622-3","article-title":"Molecular cloning, functional expression, pharmacological characterization and chromosomal localization of the human metabotropic glutamate receptor type 3","volume":"35","author":"Emile","year":"1996","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib127","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1042\/bj20021750","article-title":"Different binding motifs in metabotropic glutamate receptor type 7b for filamin A, protein phosphatase 1C, protein interacting with protein kinase C (PICK) 1 and syntenin allow the formation of multimeric protein complexes","volume":"372","author":"Enz","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib128","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/nm.2183","article-title":"Metabotropic glutamate receptor-4 modulates adaptive immunity and restrains neuroinflammation","volume":"16","author":"Fallarino","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib129","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.neuropharm.2008.06.066","article-title":"Switch in the expression of mGlu1 and mGlu5 metabotropic glutamate receptors in the cerebellum of mice developing experimental autoimmune encephalomyelitis and in autoptic cerebellar samples from patients with multiple sclerosis","volume":"55","author":"Fazio","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib130","doi-asserted-by":"crossref","first-page":"10520","DOI":"10.1523\/JNEUROSCI.2547-05.2005","article-title":"Metabotropic glutamate receptor 8-expressing nerve terminals target subsets of GABAergic neurons in the hippocampus","volume":"25","author":"Ferraguti","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib131","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s00441-006-0266-5","article-title":"Metabotropic glutamate receptors","volume":"326","author":"Ferraguti","year":"2006","journal-title":"Cell. Tissue Res."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib132","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1124\/pr.108.000166","article-title":"Metabotropic glutamate 1 receptor: current concepts and perspectives","volume":"60","author":"Ferraguti","year":"2008","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib133","doi-asserted-by":"crossref","first-page":"11940","DOI":"10.1073\/pnas.172393799","article-title":"Synergistic interaction between adenosine A2A and glutamate mGlu5 receptors: implications for striatal neuronal function","volume":"99","author":"Ferr\u00e9","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib134","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1177\/026988110101500203","article-title":"Interactions between LY354740, a group II metabotropic agonist and the GABA(A)-benzodiazepine receptor complex in the rat elevated plus-maze","volume":"15","author":"Ferris","year":"2001","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib135","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/tpj.2009.24","article-title":"Candidate-gene association analysis of response to risperidone in African-American and white patients with schizophrenia","volume":"9","author":"Fijal","year":"2009","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib136","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0091-3057(02)00832-8","article-title":"Antinociceptive effects following intrathecal pretreatment with selective metabotropic glutamate receptor compounds in a rat model of neuropathic pain","volume":"73","author":"Fisher","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib137","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1460-9568.1995.tb00666.x","article-title":"Molecular cloning, functional expression and pharmacological characterization of the human metabotropic glutamate receptor type 2","volume":"7","author":"Flor","year":"1995","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib138","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0028-3908(94)00149-M","article-title":"Molecular cloning, functional expression and pharmacological characterization of the human metabotropic glutamate receptor type 4","volume":"34","author":"Flor","year":"1995","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib139","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0028-3908(96)00176-1","article-title":"A novel splice variant of a metabotropic glutamate receptor, human mGluR7b","volume":"36","author":"Flor","year":"1997","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib140","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1124\/mol.106.030254","article-title":"Amino-pyrrolidine tricarboxylic acids give new insight into group III metabotropic glutamate receptor activation mechanism","volume":"71","author":"Frauli","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib141","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1093\/hmg\/ddn402","article-title":"GRM7 variants confer susceptibility to age-related hearing impairment","volume":"18","author":"Friedman","year":"2009","journal-title":"Hum. Mol. Genet."},{"issue":"3","key":"10.1016\/j.neuropharm.2010.10.022_bib142","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1053\/j.gastro.2005.06.069","article-title":"Inhibition of transient lower esophageal sphincter relaxation and gastroesophageal reflux by metabotropic glutamate receptor ligands","volume":"129","author":"Frisby","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib143","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/sj.bjp.0701174","article-title":"Attenuation of precipitated morphine withdrawal symptoms by acute i.c.v. administration of a group II mGluR agonist","volume":"121","author":"Fundytus","year":"1997","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib144","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0006-8993(94)90857-5","article-title":"(2S,1\u2019R,2\u2019R,3\u2019R)-2-(2,3-dicarboxycyclopropyl) glycine positively modulates metabotropic glutamate receptors coupled to polyphosphoinositide hydrolysis in rat hippocampal slices","volume":"659","author":"Genazzani","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib145","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0893-133X(00)00136-6","article-title":"Behavioral evidence for interactions between a hallucinogenic drug and group II metabotropic glutamate receptors","volume":"23","author":"Gewirtz","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib146","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1093\/brain\/awg179","article-title":"Altered expression patterns of group I and II metabotropic glutamate receptors in multiple sclerosis","volume":"126","author":"Geurts","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib147","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nm850","article-title":"Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease","volume":"9","author":"Gill","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib148","doi-asserted-by":"crossref","first-page":"8908","DOI":"10.1523\/JNEUROSCI.0932-05.2005","article-title":"A reduced number of metabotropic glutamate subtype 5 receptors are associated with constitutive homer proteins in a mouse model of fragile X syndrome","volume":"25","author":"Giuffrida","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib149","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nature06612","article-title":"Identification of a serotonin\/glutamate receptor complex implicated in psychosis","volume":"452","author":"Gonz\u00e1lez-Maeso","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib150","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1073\/pnas.0304699101","article-title":"Heptahelical domain of metabotropic glutamate receptor 5 behaves like rhodopsin-like receptors","volume":"101","author":"Goudet","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib151","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.pain.2007.08.020","article-title":"Group III metabotropic glutamate receptors inhibit hyperalgesia in animal models of inflammation and neuropathic pain","volume":"137","author":"Goudet","year":"2008","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib152","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.brainresrev.2008.12.007","article-title":"Metabotropic receptors for glutamate and GABA in pain","volume":"60","author":"Goudet","year":"2009","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib153","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/sj.npp.1300672","article-title":"Group II and III metabotropic glutamate receptors suppress excitatory synaptic transmission in the dorsolateral bed nucleus of the stria terminalis","volume":"30","author":"Grueter","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib154","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.pneurobio.2004.09.005","article-title":"Metabotropic glutamate receptors and striatal synaptic plasticity: implications for neurological diseases","volume":"74","author":"Gubellini","year":"2004","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib155","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.pain.2004.10.022","article-title":"mGluR1 and mGluR5 antagonists in the amygdala inhibit different components of audible and ultrasonic vocalizations in a model of arthritic pain","volume":"113","author":"Han","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib156","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/nm0810-856","article-title":"Glutamate joins the ranks of immunomodulators","volume":"16","author":"Hansen","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib157","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1111\/j.1460-9568.1997.tb01477.x","article-title":"The whole nucleotide sequence and chromosomal localization of the gene for human metabotropic glutamate receptor subtype 6","volume":"9","author":"Hashimoto","year":"1997","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib158","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/366687a0","article-title":"Role of a metabotropic glutamate receptor in synaptic modulation in the accessory olfactory bulb","volume":"366","author":"Hayashi","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib159","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ejphar.2010.03.046","article-title":"Pharmacological effects of metabotropic glutamate receptor ligands on prepulse inhibition in DBA\/2j mice","volume":"639","author":"Hikichi","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib160","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/sj.emboj.7600557","article-title":"Evidence for a single heptahelical domain being turned on upon activation of a dimeric GPCR","volume":"24","author":"Hlavackova","year":"2005","journal-title":"EMBO J."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib161","doi-asserted-by":"crossref","first-page":"7444","DOI":"10.1523\/JNEUROSCI.22-17-07444.2002","article-title":"Prostaglandin and protein kinase A-dependent modulation of vanilloid receptor function by metabotropic glutamate receptor 5: potential mechanism for thermal hyperalgesia","volume":"22","author":"Hu","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib162","doi-asserted-by":"crossref","first-page":"13181","DOI":"10.1523\/JNEUROSCI.0269-07.2007","article-title":"Metabotropic glutamate receptor 5 modulates nociceptive plasticity via extracellular signal-regulated kinase-Kv4.2 signaling in spinal cord dorsal horn neurons","volume":"27","author":"Hu","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib163","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1126\/science.288.5469.1254","article-title":"Role for rapid dendritic protein synthesis in hippocampal mGluR-dependent long-term depression","volume":"288","author":"Huber","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib164","doi-asserted-by":"crossref","first-page":"7746","DOI":"10.1073\/pnas.122205699","article-title":"Altered synaptic plasticity in a mouse model of fragile X mental retardation","volume":"99","author":"Huber","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib165","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1046\/j.1471-4159.2002.00929.x","article-title":"Native group-III metabotropic glutamate receptors are coupled to the mitogen-activated protein kinase\/phosphatidylinositol-3-kinase pathways","volume":"82","author":"Iacovelli","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib166","doi-asserted-by":"crossref","first-page":"12433","DOI":"10.1074\/jbc.M203992200","article-title":"Role of G protein-coupled receptor kinase 4 and beta-arrestin 1 in agonist-stimulated metabotropic glutamate receptor 1 internalization and activation of mitogen-activated protein kinases","volume":"278","author":"Iacovelli","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib167","doi-asserted-by":"crossref","first-page":"8388","DOI":"10.1523\/JNEUROSCI.2285-06.2006","article-title":"Pharmacological activation of mGlu4 metabotropic glutamate receptors inhibits the growth of medulloblastomas","volume":"26","author":"Iacovelli","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib168","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1124\/mol.108.052316","article-title":"Regulation of group II metabotropic glutamate receptors by G protein-coupled receptor kinases: mGlu2 receptors are resistant to homologous desensitization","volume":"75","author":"Iacovelli","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib169","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1126\/science.288.5472.1832","article-title":"mGluR1 in cerebellar Purkinje cells essential for long-term depression, synapse elimination, and motor coordination","volume":"288","author":"Ichise","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib170","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/0896-6273(95)90341-0","article-title":"Heterologous expression of metabotropic glutamate receptors in adult rat sympathetic neurons: subtype-specific coupling to ion channels","volume":"14","author":"Ikeda","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib171","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1046\/j.1365-2443.1999.00269.x","article-title":"Competitive interaction of seven in absentia homolog-1A and Ca2+\/calmodulin with the cytoplasmic tail of group 1 metabotropic glutamate receptors","volume":"4","author":"Ishikawa","year":"1999","journal-title":"Genes Cells"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib172","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/ajmg.b.20024","article-title":"Candidate gene analysis of the human metabotropic glutamate receptor type 4 (GRM4) in patients with juvenile myoclonic epilepsy","volume":"123","author":"Izzi","year":"2003","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib173","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.neuropharm.2009.04.011","article-title":"The anxiolytic and analgesic properties of fenobam, a potent mGlu5 receptor antagonist, in relation to the impairment of learning","volume":"57","author":"Jacob","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib174","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ejphar.2005.07.007","article-title":"Transient lower esophageal sphincter relaxations in dogs are inhibited by a metabotropic glutamate receptor 5 antagonist","volume":"519","author":"Jensen","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib175","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/jat.1413","article-title":"Selective blockade of mGlu5 metabotropic glutamate receptors is hepatoprotective against fulminant hepatic failure induced by lipopolysaccharide and d-galactosamine in mice","volume":"29","author":"Jesse","year":"2009","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib176","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1101\/lm.5.4.331","article-title":"Selective abolition of the NMDA component of long-term potentiation in mice lacking mGluR5","volume":"5","author":"Jia","year":"1998","journal-title":"Learn. Mem."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib177","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.neuron.2007.06.035","article-title":"Long-term depression of mGluR1 signaling","volume":"55","author":"Jin","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib178","doi-asserted-by":"crossref","first-page":"3970","DOI":"10.1523\/JNEUROSCI.15-05-03970.1995","article-title":"Molecular, functional, and pharmacological characterization of the metabotropic glutamate receptor type 5 splice variants: comparison with mGluR1","volume":"15","author":"Joly","year":"1995","journal-title":"J. Neurosci."},{"issue":"Suppl 1","key":"10.1016\/j.neuropharm.2010.10.022_bib435","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.neuropharm.2005.05.008","article-title":"Analgesic effects of the selective group II (mGlu2\/3) metabotropic glutamate receptor agonists LY379268 and LY389795 in persistent and inflammatory pain models after acute and repeated dosing","volume":"49","author":"Jones","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib179","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1159\/000218076","article-title":"DTNBP1, NRG1, DAOA, DAO and GRM3 polymorphisms and schizophrenia: an association study","volume":"59","author":"J\u00f6nsson","year":"2009","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib180","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1124\/jpet.110.166629","article-title":"Reduction of l-DOPA-induced dyskinesia by the selective metabotropic glutamate receptor 5 antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson\u2019s disease","volume":"333","author":"Johnston","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib181","unstructured":"Julio-Pieper, M., Flor, P.J., Dinan, T.G., Cryan, J.F. Exciting times beyond the brain: metabotropic glutamate receptors in peripheral and non-neural tissues. Pharmacol. Rev., in press."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib182","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1126\/science.8023145","article-title":"Induction of an olfactory memory by the activation of a metabotropic glutamate receptor","volume":"265","author":"Kaba","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib183","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0304-3940(01)02397-7","article-title":"Group 2 metabotropic glutamate receptors induced long term depression in mouse striatal slices","volume":"316","author":"Kahn","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib184","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nrn2515","article-title":"The glutamate homeostasis hypothesis of addiction","volume":"10","author":"Kalivas","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib185","doi-asserted-by":"crossref","first-page":"7238","DOI":"10.1523\/JNEUROSCI.20-19-07238.2000","article-title":"Homer proteins regulate coupling of group I metabotropic glutamate receptors to N-type calcium and M-type potassium channels","volume":"20","author":"Kammermeier","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib186","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1471-2202-2-15","article-title":"A role for Seven in Absentia Homolog (Siah1a) in metabotropic glutamate receptor signaling","volume":"2","author":"Kammermeier","year":"2001","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib187","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0896-6273(01)80047-7","article-title":"Persistent multiple climbing fiber innervation of cerebellar Purkinje cells in mice lacking mGluR1","volume":"18","author":"Kano","year":"1997","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib188","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1098\/rstb.2008.2270","article-title":"Type-1 metabotropic glutamate receptor in cerebellar Purkinje cells: a key molecule responsible for long-term depression, endocannabinoid signalling and synapse elimination","volume":"363","author":"Kano","year":"2008","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib189","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.neulet.2005.09.058","article-title":"The metabotropic glutamate 2\/3 receptor antagonist, MGS0039, increases extracellular dopamine levels in the nucleus accumbens shell","volume":"393","author":"Karasawa","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib190","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1017\/S1461145707008097","article-title":"New treatments for cocaine dependence: a focused review","volume":"11","author":"Karila","year":"2008","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib191","doi-asserted-by":"crossref","first-page":"23969","DOI":"10.1074\/jbc.273.37.23969","article-title":"Novel members of the Vesl\/Homer family of PDZ proteins that bind metabotropic glutamate receptors","volume":"273","author":"Kato","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib192","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/nrn2234","article-title":"Synaptic plasticity and addiction","volume":"8","author":"Kauer","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib193","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/383089a0","article-title":"Control of calcium oscillations by phosphorylation of metabotropic glutamate receptors","volume":"383","author":"Kawabata","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib194","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1124\/jpet.103.052027","article-title":"Group II metabotropic and alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)\/kainate glutamate receptors regulate the deficit in brain reward function associated with nicotine withdrawal in rats","volume":"306","author":"Kenny","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib195","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.tips.2004.03.009","article-title":"The ups and downs of addiction: role of metabotropic glutamate receptors","volume":"25","author":"Kenny","year":"2004","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib196","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00213-004-2069-2","article-title":"Metabotropic glutamate 5 receptor blockade may attenuate cocaine self-administration by decreasing brain reward function in rats","volume":"179","author":"Kenny","year":"2005","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib197","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1586\/ecp.09.6","article-title":"Emergic therapeutic targets for the treatments of nicotine addiction","volume":"2","author":"Kenny","year":"2009","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib198","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1136\/gut.2008.162040","article-title":"A proof-of-concept study evaluating the effect of ADX10059, a metabotropic glutamate receptor-5 negative allosteric modulator, on acid exposure and symptoms in gastro-oesophageal reflux disease","volume":"58","author":"Keywood","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib199","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1152\/jn.2001.85.6.2509","article-title":"Presynaptic group II mGluR inhibition of short-term depression in the medial perforant path of the dentate gyrus in vitro","volume":"85","author":"Kilbride","year":"2001","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib200","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1124\/jpet.103.048702","article-title":"Metabotropic glutamate subtype 5 receptors modulate locomotor activity and sensorimotor gating in rodents","volume":"306","author":"Kinney","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib201","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1523\/JNEUROSCI.22-04-01280.2002","article-title":"Tamalin, a PDZ domain-containing protein, links a protein complex formation of group 1 metabotropic glutamate receptors and the guanine nucleotide exchange factor cytohesins","volume":"22","author":"Kitano","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib202","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0091-3057(02)00845-6","article-title":"Group II mGlu receptor agonists inhibit behavioural and electrophysiological effects of DOI in mice","volume":"73","author":"K\u0142odzinska","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib203","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.biopsych.2008.10.040","article-title":"The role of cystine-glutamate exchange in nicotine dependence in rats and humans","volume":"65","author":"Knackstedt","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib204","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/nsmb794","article-title":"Closed state of both binding domains of homodimeric mGlu receptors is required for full activity","volume":"11","author":"Kniazeff","year":"2004","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib205","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1523\/JNEUROSCI.3141-03.2004","article-title":"Locking the dimeric GABAB G-protein coupled receptor in its active state","volume":"24","author":"Kniazeff","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib206","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1073\/pnas.0912730107","article-title":"TRPM1 is a component of the retinal ON bipolar cell transduction channel in the mGluR6 cascade","volume":"107","author":"Koike","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib207","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev.psych.59.103006.093548","article-title":"Addiction and the brain antireward system","volume":"59","author":"Koob","year":"2008","journal-title":"Annu. Rev. Psychol."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib208","doi-asserted-by":"crossref","first-page":"9909","DOI":"10.1073\/pnas.96.17.9909","article-title":"Modulation of the intracellular calcium concentration in photoreceptor terminals by a presynaptic metabotropic glutamate receptor","volume":"96","author":"Koulen","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib209","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1167\/iovs.04-0963","article-title":"Interaction between mGluR8 and calcium channels in photoreceptors is sensitive to pertussis toxin and occurs via G protein betagamma subunit signaling","volume":"46","author":"Koulen","year":"2005","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib210","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00213-002-1287-8","article-title":"Inhibitory effects of MPEP, an mGluR5 antagonist, and memantine, an N-methyl-d-aspartate receptor antagonist, on morphine antinociceptive tolerance in mice","volume":"165","author":"Kozela","year":"2003","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib211","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/35039564","article-title":"Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor","volume":"407","author":"Kunishima","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib212","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1006\/geno.1994.1069","article-title":"Gene mapping of NMDA receptors and metabotropic glutamate receptors in the rat (Rattus norvegicus)","volume":"19","author":"Kuramoto","year":"1994","journal-title":"Genomics"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib213","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.mcn.2006.10.010","article-title":"Molecular alterations in the cerebellum of the plasma membrane calcium ATPase 2 (PMCA2)-null mouse indicate abnormalities in Purkinje neurons","volume":"34","author":"Kurnellas","year":"2007","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib214","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0074-7742(09)85023-X","article-title":"Involvement of endocannabinoid signaling in the neuroprotective effects of subtype 1 metabotropic glutamate receptor antagonists in models of cerebral ischemia","volume":"85","author":"Landucci","year":"2009","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib215","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1176\/ajp.2007.164.7.1115","article-title":"Malcolm R.Is cocaine desire reduced by N-acetylcysteine?","volume":"164","author":"LaRowe","year":"2007","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib216","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/10550490500419169","article-title":"Safety and tolerability of N-acetylcysteine in cocaine-dependent individuals","volume":"15","author":"LaRowe","year":"2006","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib217","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0028-3908(96)00172-4","article-title":"Cloning, distribution and functional expression of the human mGlu6 metabotropic glutamate receptor","volume":"36","author":"Laurie","year":"1997","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib218","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.neuropharm.2004.08.007","article-title":"JNJ16259685, a highly potent, selective and systemically active mGlu1 receptor antagonist","volume":"47","author":"Lavreysen","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib219","doi-asserted-by":"crossref","first-page":"671","DOI":"10.2174\/092986708783885246","article-title":"Therapeutic potential of group III metabotropic glutamate receptors","volume":"15","author":"Lavreysen","year":"2008","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib220","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.biopsych.2006.12.003","article-title":"Positive allosteric modulation of metabotropic glutamate 5 (mGlu5) receptors reverses N-Methyl-d-aspartate antagonist-induced alteration of neuronal firing in prefrontal cortex","volume":"62","author":"Lecourtier","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib221","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ejphar.2006.10.011","article-title":"Interactive effects of the mGlu5 receptor antagonist MPEP and the mGlu2\/3 receptor antagonist LY341495 on nicotine self-administration and reward deficits associated with nicotine withdrawal in rats","volume":"554","author":"Liechti","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib222","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1126\/science.8493557","article-title":"GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons","volume":"260","author":"Lin","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib223","doi-asserted-by":"crossref","first-page":"9017","DOI":"10.1523\/JNEUROSCI.20-24-09017.2000","article-title":"Activation of group II metabotropic glutamate receptors induces long-term depression of synaptic transmission in the rat amygdala","volume":"20","author":"Lin","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib224","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1101\/lm.85304","article-title":"Activation of group II metabotropic glutamate receptors induces depotentiation in amygdala slices and reduces fear-potentiated startle in rats","volume":"12","author":"Lin","year":"2005","journal-title":"Learn. Mem."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib225","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0028-3908(02)00079-5","article-title":"Increased anxiety-related behavior in mice deficient for metabotropic glutamate 8 (mGlu8) receptor","volume":"43","author":"Linden","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib226","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0306-4522(03)00393-2","article-title":"Increased anxiety-related behavior in the elevated plus maze associated with the increased C-FOS expression in the centromedial nucleus of the thalamus in mGlu8 receptor knockout mice","volume":"121","author":"Linden","year":"2003","journal-title":"Neuroscience"},{"issue":"Suppl. 1","key":"10.1016\/j.neuropharm.2010.10.022_bib227","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.neuropharm.2005.05.006","article-title":"Comparison of c-Fos induction in the brain by the mGlu2\/3 receptor antagonist LY341495 and agonist LY354740: evidence for widespread endogenous tone at brain mGlu2\/3 receptors in vivo","volume":"49","author":"Linden","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib228","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.neuropharm.2006.03.014","article-title":"Effects of mGlu2 or mGlu3 receptor deletions on mGlu2\/3 receptor agonist (LY354740)-induced brain c-Fos expression: specific roles for mGlu2 in the amygdala and subcortical nuclei, and mGlu3 in the hippocampus","volume":"51","author":"Linden","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib229","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.ddstr.2006.10.018","article-title":"Metabotropic glutamate receptors targets for neuropsychiatric disorders","volume":"3","author":"Linden","year":"2006","journal-title":"Drug Discov. Today Ther. Strateg."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib230","doi-asserted-by":"crossref","first-page":"11062","DOI":"10.1073\/pnas.191353898","article-title":"Regulation of cyclin-dependent kinase 5 and casein kinase 1 by metabotropic glutamate receptors","volume":"98","author":"Liu","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib231","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1124\/jpet.108.136580","article-title":"ADX47273 [S-(4-fluoro-phenyl)-{3-[3-(4-fluoro-phenyl)-[1,2,4]-oxadiazol-5-yl]-piperidin-1-yl}-methanone]: a novel metabotropic glutamate receptor 5-selective positive allosteric modulator with preclinical antipsychotic-like and precognitive activities","volume":"327","author":"Liu","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib232","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.neuropharm.2010.01.008","article-title":"Neurotransmitter roles in synaptic modulation, plasticity and learning in the dorsal striatum","volume":"58","author":"Lovinger","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib233","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/jnr.20230","article-title":"Cytoskeletal protein 4.1G is a binding partner of the metabotropic glutamate receptor subtype 1 alpha","volume":"78","author":"Lu","year":"2004","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib234","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0891-0618(97)00051-3","article-title":"Differential plasma membrane distribution of metabotropic glutamate receptors mGluR1 alpha, mGluR2 and mGluR5, relative to neurotransmitter release sites","volume":"13","author":"Luj\u00e1n","year":"1997","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib235","doi-asserted-by":"crossref","first-page":"4409","DOI":"10.1113\/jphysiol.2008.157289","article-title":"Allelic variance between GRM6 mutants, Grm6nob3 and Grm6nob4 results in differences in retinal ganglion cell visual responses","volume":"586","author":"Maddox","year":"2008","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib236","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0169-328X(99)00050-9","article-title":"Cloning and functional expression of alternative spliced variants of the human metabotropic glutamate receptor 8","volume":"67","author":"Malherbe","year":"1999","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib237","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0169-328X(02)00557-0","article-title":"Identification and characterization of a novel splice variant of the metabotropic glutamate receptor 5 gene in human hippocampus and cerebellum","volume":"109","author":"Malherbe","year":"2002","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib238","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/S0028-3908(98)00150-6","article-title":"Priming of group 2 metabotropic glutamate receptors facilitates induction of long-term depression in the dentate gyrus of freely moving rats","volume":"37","author":"Manahan-Vaughan","year":"1998","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib239","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1093\/cercor\/bhi047","article-title":"The metabotropic glutamate receptor, mGluR5, is a key determinant of good and bad spatial learning performance and hippocampal synaptic plasticity","volume":"15","author":"Manahan-Vaughan","year":"2005","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib240","doi-asserted-by":"crossref","first-page":"5925","DOI":"10.1523\/JNEUROSCI.21-16-05925.2001","article-title":"Metabotropic glutamate receptors 1 and 5 differentially regulate CA1 pyramidal cell function","volume":"21","author":"Mannaioni","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib241","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1152\/jn.00356.2007","article-title":"Periaqueductal gray metabotropic glutamate receptor subtype 7 and 8 mediate opposite effects on amino acid release, rostral ventromedial medulla cell activities, and thermal nociception","volume":"98","author":"Marabese","year":"2007","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib242","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.neuropharm.2006.04.006","article-title":"Effects of (S)-3,4-DCPG, an mGlu8 receptor agonist, on inflammatory and neuropathic pain in mice","volume":"52","author":"Marabese","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib243","doi-asserted-by":"crossref","first-page":"11388","DOI":"10.1073\/pnas.0901290106","article-title":"Optical measurement of mGluR1 conformational changes reveals fast activation, slow deactivation, and sensitization","volume":"106","author":"Marcaggi","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib244","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.pnpbp.2006.10.001","article-title":"An open-label trial of N-acetylcysteine for the treatment of cocaine dependence: a pilot study","volume":"31","author":"Mardikian","year":"2007","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib245","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0022-3565(24)35262-0","article-title":"Physiological antagonism between 5-hydroxytryptamine(2A) and group II metabotropic glutamate receptors in prefrontal cortex","volume":"292","author":"Marek","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib246","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1001\/archneurol.2010.51","article-title":"Metabotropic glutamate receptor type 1 autoantibody-associated cerebellitis: a primary autoimmune disease?","volume":"67","author":"Marignier","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib247","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.cellsig.2005.10.012","article-title":"Stimulation of oncogenic metabotropic glutamate receptor 1 in melanoma cells activates ERK1\/2 via PKCepsilon","volume":"18","author":"Mar\u00edn","year":"2006","journal-title":"Cell Signal."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib248","doi-asserted-by":"crossref","first-page":"13668","DOI":"10.1073\/pnas.1835724100","article-title":"Allosteric modulation of group III metabotropic glutamate receptor 4: a potential approach to Parkinson\u2019s disease treatment","volume":"100","author":"Marino","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib249","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/ajmg.1622","article-title":"Human metabotropic glutamate receptor 2 gene (GRM2): chromosomal sublocalization (3p21.1-p21.2) and genomic organization","volume":"114","author":"Mart\u00ed","year":"2002","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib250","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0896-6273(92)90165-A","article-title":"Cellular localization of a metabotropic glutamate receptor in rat brain","volume":"9","author":"Martin","year":"1992","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib251","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.neuropharm.2008.04.011","article-title":"The inhibition of release by mGlu7 receptors is independent of the Ca2+ channel type but associated to GABAB and adenosine A1 receptors","volume":"55","author":"Mart\u00edn","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib252","doi-asserted-by":"crossref","first-page":"17907","DOI":"10.1074\/jbc.M109.080838","article-title":"The metabotropic glutamate receptor mGlu7 activates phospholipase C, translocates munc-13-1 protein, and potentiates glutamate release at cerebrocortical nerve terminals","volume":"285","author":"Mart\u00edn","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib253","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/349760a0","article-title":"Sequence and expression of a metabotropic glutamate receptor","volume":"349","author":"Masu","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib254","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/0092-8674(95)90354-2","article-title":"Specific deficit of the ON response in visual transmission by targeted disruption of the mGluR6 gene","volume":"80","author":"Masu","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib255","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1074\/jbc.M109.058511","article-title":"Membrane anchor R9AP potentiates GTPase-accelerating protein activity of RGS11\u00a0\u00d7\u00a0Gbeta5 complex and accelerates inactivation of the mGluR6-G(o) signaling","volume":"285","author":"Masuho","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib256","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/(SICI)1096-9861(19980112)390:2<225::AID-CNE5>3.0.CO;2-3","article-title":"Immunocytochemical localization of the mGluR1b metabotropic glutamate receptor in the rat hypothalamus","volume":"390","author":"Mateos","year":"1998","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib257","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1038\/sj.bjp.0705159","article-title":"Positive allosteric modulation of the human metabotropic glutamate receptor 4 (hmGluR4) by SIB-1893 and MPEP","volume":"138","author":"Mathiesen","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib258","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1111\/j.1471-4159.2005.03141.x","article-title":"Metabotropic glutamate receptors and neuroadaptation to antidepressants: imipramine-induced down-regulation of beta-adrenergic receptors in mice treated with metabotropic glutamate 2\/3 receptor ligands","volume":"93","author":"Matrisciano","year":"2005","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib259","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/sj.mp.4002005","article-title":"Group-II metabotropic glutamate receptor ligands as adjunctive drugs in the treatment of depression: a new strategy to shorten the latency of antidepressant medication?","volume":"12","author":"Matrisciano","year":"2007","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib260","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nmeth.1213","article-title":"Cell surface protein-protein interaction analysis with combined time-resolved FRET and snap-tag technologies: application to GPCR oligomerization","volume":"5","author":"Maurel","year":"2008","journal-title":"Nat. Methods"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib261","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1471-4159.2007.04456.x","article-title":"Antagonism of metabotropic glutamate receptor type 5 attenuates l-DOPA-induced dyskinesia and its molecular and neurochemical correlates in a rat model of Parkinson\u2019s disease","volume":"101","author":"Mela","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib262","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.neuropharm.2007.05.031","article-title":"Metabotropic glutamate receptors in stem\/progenitor cells","volume":"53","author":"Melchiorri","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib263","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1046\/j.1471-4159.1996.67041435.x","article-title":"Exposure of astrocytes to thrombin reduces levels of the metabotropic glutamate receptor mGluR5","volume":"67","author":"Miller","year":"1996","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib264","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1046\/j.1471-4159.1995.65041536.x","article-title":"The expression of two splice variants of metabotropic glutamate receptor subtype 5 in the rat brain and neuronal cells during development","volume":"65","author":"Minakami","year":"1995","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib265","doi-asserted-by":"crossref","first-page":"18712","DOI":"10.1073\/pnas.0508063102","article-title":"A selective metabotropic glutamate receptor 7 agonist: activation of receptor signaling via an allosteric site modulates stress parameters in vivo","volume":"102","author":"Mitsukawa","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib266","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1126\/science.281.5381.1349","article-title":"Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats","volume":"281","author":"Moghaddam","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib267","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1124\/mol.109.056580","article-title":"Activation of mGlu2\/3 metabotropic glutamate receptors negatively regulates the stimulation of inositol phospholipid hydrolysis mediated by 5-hydroxytryptamine2A serotonin receptors in the frontal cortex of living mice","volume":"76","author":"Molinaro","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib268","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1124\/jpet.109.154138","article-title":"The metabotropic glutamate receptor subtype 5 antagonist fenobam is analgesic and has improved in vivo selectivity compared with the prototypical antagonist 2-methyl-6-(phenylethynyl)-pyridine","volume":"330","author":"Montana","year":"2009","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib269","doi-asserted-by":"crossref","first-page":"6389","DOI":"10.1523\/JNEUROSCI.1007-05.2005","article-title":"Cystine\/glutamate exchange regulates metabotropic glutamate receptor presynaptic inhibition of excitatory transmission and vulnerability to cocaine seeking","volume":"25","author":"Moran","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib270","doi-asserted-by":"crossref","first-page":"19174","DOI":"10.1073\/pnas.0908711106","article-title":"TRPM1 is required for the depolarizing light response in retinal ON-bipolar cells","volume":"106","author":"Morgans","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib271","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.1073\/pnas.0500914102","article-title":"Enhanced cocaine responsiveness and impaired motor coordination in metabotropic glutamate receptor subtype 2 knockout mice","volume":"102","author":"Morishima","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib272","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1113\/jphysiol.2008.153122","article-title":"Co-activation of p38 mitogen-activated protein kinase and protein tyrosine phosphatase underlies metabotropic glutamate receptor-dependent long-term depression","volume":"586","author":"Moult","year":"2008","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib273","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nn.2250","article-title":"N-Acetylcysteine reverses cocaine-induced metaplasticity","volume":"12","author":"Moussawi","year":"2009","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib274","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0091-3057(02)00842-0","article-title":"Evaluation of the mGluR2\/3 agonist LY379268 in rodent models of Parkinson\u2019s disease","volume":"73","author":"Murray","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib275","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1073\/pnas.0611577104","article-title":"Structures of the extracellular regions of the group II\/III metabotropic glutamate receptors","volume":"104","author":"Muto","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib276","doi-asserted-by":"crossref","first-page":"11868","DOI":"10.1016\/S0021-9258(19)50280-0","article-title":"Molecular characterization of a novel retinal metabotropic glutamate receptor mGluR6 with a high agonist selectivity for l-2-amino-4-phosphonobutyrate","volume":"268","author":"Nakajima","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib277","doi-asserted-by":"crossref","first-page":"4570","DOI":"10.1021\/jm0400294","article-title":"Synthesis, in vitro pharmacology, structure-activity relationships, and pharmacokinetics of 3-alkoxy-2-amino-6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivatives as potent and selective group II metabotropic glutamate receptor antagonists","volume":"47","author":"Nakazato","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib278","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1158\/0008-5472.CAN-06-3665","article-title":"Metabotropic glutamate receptor 1 and glutamate signaling in human melanoma","volume":"67","author":"Namkoong","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib279","doi-asserted-by":"crossref","first-page":"4471","DOI":"10.1523\/JNEUROSCI.20-12-04471.2000","article-title":"Regulation of the ON bipolar cell mGluR6 pathway by Ca2+","volume":"20","author":"Nawy","year":"2000","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib280","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1523\/JNEUROSCI.19-08-02938.1999","article-title":"The metabotropic receptor mGluR6 may signal through G(o), but not phosphodiesterase, in retinal bipolar cells","volume":"19","author":"Nawy","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib281","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0304-3940(95)12248-6","article-title":"Pre- and postsynaptic localization of a metabotropic glutamate receptor, mGluR2, in the rat brain: an immunohistochemical study with a monoclonal antibody","volume":"202","author":"Neki","year":"1996","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib282","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0166-2236(00)02007-5","article-title":"Peripheral metabotropic glutamate receptors: fight the pain where it hurts","volume":"24","author":"Neugebauer","year":"2001","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib283","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.neuropharm.2007.10.004","article-title":"Positive allosteric modulation of metabotropic glutamate 4 (mGlu4) receptors enhances spontaneous and evoked absence seizures","volume":"54","author":"Ngomba","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib284","doi-asserted-by":"crossref","first-page":"6380","DOI":"10.1073\/pnas.0601267103","article-title":"mGluR2 acts through inhibitory Galpha subunits to regulate transmission and long-term plasticity at hippocampal mossy fiber-CA3 synapses","volume":"103","author":"Nicholls","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib285","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1073\/pnas.83.6.1931","article-title":"Excitatory amino acid recognition sites coupled with inositol phospholipid metabolism: developmental changes and interaction with alpha 1-adrenoceptors","volume":"83","author":"Nicoletti","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib286","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1471-4159.1986.tb12922.x","article-title":"Coupling of inositol phospholipid metabolism with excitatory amino acid recognition sites in rat hippocampus","volume":"46","author":"Nicoletti","year":"1986","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib287","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0028-3908(86)90262-5","article-title":"Serine-O-phosphate, an endogenous metabolite, inhibits the stimulation of inositol phospholipid hydrolysis elicited by ibotenic acid in rat hippocampal slices","volume":"25","author":"Nicoletti","year":"1986","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib288","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/S0028-3908(99)00102-1","article-title":"Group-I metabotropic glutamate receptors: hypotheses to explain their dual role in neurotoxicity and neuroprotection","volume":"38","author":"Nicoletti","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib289","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s00439-006-0257-3","article-title":"Evidence for statistical epistasis between catechol-O-methyltransferase (COMT) and polymorphisms in RGS4, G72 (DAOA), GRM3, and DISC1: influence on risk of schizophrenia","volume":"120","author":"Nicodemus","year":"2007","journal-title":"Hum. Genet."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib290","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1073\/pnas.0237126100","article-title":"Metabotropic mGlu5 receptors regulate adenosine A2A receptor signaling","volume":"100","author":"Nishi","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib291","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1124\/mol.108.049551","article-title":"Discovery, characterization, and antiparkinsonian effect of novel positive allosteric modulators of metabotropic glutamate receptor 4","volume":"74","author":"Niswender","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib292","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1146\/annurev.pharmtox.011008.145533","article-title":"Metabotropic glutamate receptors: physiology, pharmacology, and disease","volume":"50","author":"Niswender","year":"2010","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib293","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0092-8674(94)90151-1","article-title":"Developmentally regulated postsynaptic localization of a metabotropic glutamate receptor in rat rod bipolar cells","volume":"77","author":"Nomura","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib294","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ejphar.2007.04.034","article-title":"Stress-induced hyperthermia: effects of acute and repeated dosing of MPEP","volume":"568","author":"Nordquist","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib295","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1136\/bjo.2005.086678","article-title":"Congenital stationary night blindness associated with mutations in GRM6 encoding glutamate receptor MGluR6","volume":"90","author":"O\u2019Connor","year":"2006","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib296","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0896-6273(93)90269-W","article-title":"The ligand-binding domain in metabotropic glutamate receptors is related to bacterial periplasmic binding proteins","volume":"11","author":"O\u2019Hara","year":"1993","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib297","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0896-6273(94)90459-6","article-title":"Immunohistochemical localization of metabotropic glutamate receptors, mGluR2 and mGluR3, in rat cerebellar cortex","volume":"13","author":"Ohishi","year":"1994","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib298","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/cne.903350209","article-title":"Distribution of the mRNA for a metabotropic glutamate receptor (mGluR3) in the rat brain: an in situ hybridization study","volume":"335","author":"Ohishi","year":"1993","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib299","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/0306-4522(93)90485-X","article-title":"Distribution of the messenger RNA for a metabotropic glutamate receptor, mGluR2, in the central nervous system of the rat","volume":"53","author":"Ohishi","year":"1993","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib300","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0021-9258(17)42247-2","article-title":"Molecular characterization of a new metabotropic glutamate receptor mGluR7 coupled to inhibitory cyclic AMP signal transduction","volume":"269","author":"Okamoto","year":"1994","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib301","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.pain.2008.03.017","article-title":"Glutamate receptor ligands attenuate allodynia and hyperalgesia and potentiate morphine effects in a mouse model of neuropathic pain","volume":"139","author":"Osikowicz","year":"2008","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib302","article-title":"Metabotropic glutamate receptor type 5 in levodopa-induced motor complications","author":"Ouattara","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib303","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1053\/j.gastro.2004.11.062","article-title":"Metabotropic glutamate receptors inhibit mechanosensitivity in vagal sensory neurons","volume":"128","author":"Page","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib304","doi-asserted-by":"crossref","first-page":"7659","DOI":"10.1523\/JNEUROSCI.23-20-07659.2003","article-title":"Group I metabotropic glutamate receptors in the monkey striatum: subsynaptic association with glutamatergic and dopaminergic afferents","volume":"23","author":"Paquet","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib305","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.neuropharm.2008.05.007","article-title":"Group III mGluR7 and mGluR8 in the amygdala differentially modulate nocifensive and affective pain behaviors","volume":"55","author":"Palazzo","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib306","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/S0028-3908(97)00181-0","article-title":"The group I mGlu receptor agonist DHPG induces a novel form of LTD in the CA1 region of the hippocampus","volume":"36","author":"Palmer","year":"1997","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib307","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0165-1838(00)00109-0","article-title":"Roles of central glutamate, acetylcholine and CGRP receptors in gastrointestinal afferent inputs to vagal preganglionic neurones","volume":"83","author":"Partosoedarso","year":"2000","journal-title":"Auton. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib308","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/nm1632","article-title":"Activation of mGlu2\/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial","volume":"13","author":"Patil","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib309","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.neuropharm.2006.07.020","article-title":"mGluR7 undergoes rapid internalization in response to activation by the allosteric agonist AMN082","volume":"52","author":"Pelkey","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib310","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0165-6147(03)00231-1","article-title":"The distinct role of mGlu1 receptors in post-ischemic neuronal death","volume":"24","author":"Pellegrini-Giampietro","year":"2003","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib311","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/0306-4522(95)00533-1","article-title":"The metabotropic glutamate receptors, mGluR2 and mGluR3, show unique postsynaptic, presynaptic and glial localizations","volume":"71","author":"Petralia","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib312","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0092-8674(91)90125-I","article-title":"Absence of expression of the FMR-1 gene in fragile X syndrome","volume":"66","author":"Pieretti","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib313","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejphar.2005.03.028","article-title":"Anxiolytic-like effects of mGlu1 and mGlu5 receptor antagonists in rats","volume":"514","author":"Pietraszek","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib314","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.bcp.2007.09.021","article-title":"Mood disorders: regulation by metabotropic glutamate receptors","volume":"75","author":"Pilc","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib315","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0163-7258(03)00038-X","article-title":"Evolution, structure and activation mechanism of family 3\/C G-protein coupled receptors","volume":"98","author":"Pin","year":"2003","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib316","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0028-3908(94)00129-G","article-title":"The metabotropic glutamate receptors: structure and functions","volume":"34","author":"Pin","year":"1995","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib317","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0306-4522(01)00297-4","article-title":"Metabotropic glutamate receptor 5 mediates the potentiation of N-methyl-d-aspartate responses in medium spiny striatal neurons","volume":"106","author":"Pisani","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib318","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1523\/JNEUROSCI.23-01-00122.2003","article-title":"Distinct functional roles of the metabotropic glutamate receptors 1 and 5 in the rat globus pallidus","volume":"23","author":"Poisik","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib319","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/ng1148","article-title":"Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasia","volume":"34","author":"Pollock","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib320","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1124\/jpet.105.089839","article-title":"Fenobam: a clinically validated nonbenzodiazepine anxiolytic is a potent, selective, and noncompetitive mGlu5 receptor antagonist with inverse agonist activity","volume":"315","author":"Porter","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib321","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.neuropharm.2008.06.039","article-title":"Dual neurotoxic and neuroprotective role of metabotropic glutamate receptor 1 in conditions of trophic deprivation \u2013 possible role as a dependence receptor","volume":"55","author":"Pshenichkin","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib322","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/cne.21274","article-title":"Distribution of group-III metabotropic glutamate receptors in the retina","volume":"501","author":"Quraishi","year":"2007","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib323","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1073\/pnas.022618799","article-title":"Experience-dependent plasticity without long-term depression by type 2 metabotropic glutamate receptors in developing visual cortex","volume":"99","author":"Renger","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib324","doi-asserted-by":"crossref","first-page":"4346","DOI":"10.1523\/JNEUROSCI.22-11-04346.2002","article-title":"Role of p\/q-Ca2+ channels in metabotropic glutamate receptor 2\/3-dependent presynaptic long-term depression at nucleus accumbens synapses","volume":"22","author":"Robbe","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib325","doi-asserted-by":"crossref","first-page":"28612","DOI":"10.1074\/jbc.271.45.28612","article-title":"Metabotropic glutamate receptor 5 is a disulfide-linked dimer","volume":"271","author":"Romano","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib326","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/(SICI)1096-9861(19960408)367:3<403::AID-CNE6>3.0.CO;2-9","article-title":"Enhanced early developmental expression of the metabotropic glutamate receptor mGluR5 in rat brain: protein, mRNA splice variants, and regional distribution","volume":"367","author":"Romano","year":"1996","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib327","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/emboj.2008.64","article-title":"Functioning of the dimeric GABAB receptor extracellular domain revealed by glycan wedge scanning","volume":"27","author":"Rondard","year":"2008","journal-title":"EMBO J."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib328","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1523\/JNEUROSCI.5019-07.2008","article-title":"Homer interactions are necessary for metabotropic glutamate receptor-induced long-term depression and translational activation","volume":"28","author":"Ronesi","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib329","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1038\/nn1134","article-title":"PI3 kinase enhancer-Homer complex couples mGluRI to PI3 kinase, preventing neuronal apoptosis","volume":"6","author":"Rong","year":"2003","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib330","doi-asserted-by":"crossref","first-page":"3993","DOI":"10.1016\/j.bmcl.2004.05.037","article-title":"5-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]-2,3\u2019-bipyridine: a highly potent, orally active metabotropic glutamate subtype 5 (mGlu5) receptor antagonist with anxiolytic activity","volume":"14","author":"Roppe","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib331","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1111\/j.1471-4159.2008.05331.x","article-title":"Band 4.1 proteins are expressed in the retina and interact with both isoforms of the metabotropic glutamate receptor type 8","volume":"105","author":"Rose","year":"2008","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib332","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1038\/cdd.2008.99","article-title":"Focal degeneration of astrocytes in amyotrophic lateral sclerosis","volume":"15","author":"Rossi","year":"2008","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib333","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1007\/s00415-009-5380-3","article-title":"The metabotropic glutamate receptor 1, GRM1: evaluation as a candidate gene for inherited forms of cerebellar ataxia","volume":"257","author":"Rossi","year":"2010","journal-title":"J. Neurol."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib334","doi-asserted-by":"crossref","first-page":"6121","DOI":"10.1523\/JNEUROSCI.22-14-06121.2002","volume":"22","author":"Rush","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib335","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.nbd.2010.05.001","article-title":"A mGluR5 antagonist under clinical development improves l-DOPA-induced dyskinesia in parkinsonian rats and monkeys","volume":"39","author":"Rylander","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib336","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s00335-007-9064-y","article-title":"The mouse mutants recoil wobbler and nmf373 represent a series of Grm1 mutations","volume":"18","author":"Sachs","year":"2007","journal-title":"Mamm. Genome"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib337","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1096\/fj.00-0072com","article-title":"The G-protein-coupled receptor kinase GRK4 mediates homologous desensitization of metabotropic glutamate receptor 1","volume":"14","author":"Sallese","year":"2000","journal-title":"FASEB J."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib338","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3109\/00207458808991604","article-title":"Enkephalinergic mechanisms in the \u201ccompensated\u201d phase of Parkinson\u2019s disease","volume":"42","author":"Sandyk","year":"1988","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib339","doi-asserted-by":"crossref","first-page":"8734","DOI":"10.1523\/JNEUROSCI.21-22-08734.2001","article-title":"Increased seizure susceptibility in mice lacking metabotropic glutamate receptor 7","volume":"21","author":"Sansig","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib340","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/j.1471-4159.2005.03609.x","article-title":"Alternative splicing of human metabotropic glutamate receptor 3","volume":"96","author":"Sartorius","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib341","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1124\/jpet.109.151118","article-title":"Unique antipsychotic activities of the selective metabotropic glutamate receptor 1 allosteric antagonist 2-cyclopropyl-5-[1-(2-fluoro-3-pyridinyl)-5-methyl-1H-1,2,3-triazol-4-yl]-2,3-dihydro-1H-isoindol-1-one","volume":"330","author":"Satow","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib342","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0026-895X(25)10006-0","article-title":"Cloning and expression of a new member of the l-2-amino-4-phosphonobutyric acid-sensitive class of metabotropic glutamate receptors","volume":"45","author":"Saugstad","year":"1994","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib343","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1124\/mol.51.1.119","article-title":"Cloning and expression of rat metabotropic glutamate receptor 8 reveals a distinct pharmacological profile","volume":"51","author":"Saugstad","year":"1997","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib344","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1523\/JNEUROSCI.18-03-00905.1998","article-title":"RGS4 inhibits signalling by group I metabotropic glutamate receptors","volume":"18","author":"Saugstad","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib345","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.neuropharm.2008.06.019","article-title":"Neuroprotection by group I mGlu receptors in a rat hippocampal slice model of cerebral ischemia is associated with the PI3K-Akt signaling pathway: a novel postconditioning strategy?","volume":"55","author":"Scartabelli","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib346","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1006\/geno.1996.0036","article-title":"Localization of two metabotropic glutamate receptor genes, GRM3 and GRM8, to human chromosome 7q","volume":"31","author":"Scherer","year":"1996","journal-title":"Genomics"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib347","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1006\/geno.1997.4842","article-title":"The human metabotropic glutamate receptor 8 (GRM8) gene: a disproportionately large gene located at 7q31.3-q32.1","volume":"44","author":"Scherer","year":"1997","journal-title":"Genomics"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib348","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pbb.2009.12.002","article-title":"Effects of a positive allosteric modulator of mGluR5 ADX47273 on conditioned avoidance response and PCP-induced hyperlocomotion in the rat as models for schizophrenia","volume":"95","author":"Schlumberger","year":"2009","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib349","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejphar.2009.09.006","article-title":"Comparison of the mGlu(5) receptor positive allosteric modulator ADX47273 and the mGlu(2\/3) receptor agonist LY354740 in tests for antipsychotic-like activity","volume":"623","author":"Schlumberger","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib350","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1471-4159.1989.tb07324.x","article-title":"Comparison of excitatory amino acid-stimulated phosphoinositide hydrolysis and N-[3H]acetylaspartylglutamate binding in rat brain: selective inhibition of phosphoinositide hydrolysis by 2-amino-3-phosphonopropionate","volume":"53","author":"Schoepp","year":"1989","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib351","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1111\/j.1471-4159.1991.tb02082.x","article-title":"In vitro and in vivo pharmacology of trans- and cis-(\u00b1)-1-amino-1,3-cyclopentanedicarboxylic acid: dissociation of metabotropic and ionotropic excitatory amino acid receptor effects","volume":"56","author":"Schoepp","year":"1991","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib352","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/S0028-3908(96)00121-9","article-title":"The novel metabotropic glutamate receptor agonist 2R,4R-APDC potentiates stimulation of phosphoinositide hydrolysis in the rat hippocampus by 3,5-dihydroxyphenylglycine: evidence for a synergistic interaction between group 1 and group 2 receptors","volume":"35","author":"Schoepp","year":"1996","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib353","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/S0028-3908(99)00092-1","article-title":"Pharmacological agents acting at subtypes of metabotropic glutamate receptors","volume":"38","author":"Schoepp","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib354","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2174\/1568007024606177","article-title":"Preclinical pharmacology of mGlu2\/3 receptor agonists: novel agents for schizophrenia?","volume":"1","author":"Schoepp","year":"2002","journal-title":"Curr. Drug Targets CNS Neurol. Disord."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib355","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1046\/j.1471-4159.2002.01010.x","article-title":"GABA-opioid interactions in the globus pallidus: [d-Ala2]-met-enkephalinamide attenuates potassium-evoked GABA release after nigrostriatal lesion","volume":"82","author":"Schroeder","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib356","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.neuropharm.2008.06.057","article-title":"Cue-induced reinstatement of alcohol-seeking behavior is associated with increased ERK1\/2 phosphorylation in specific limbic brain regions: blockade by the mGluR5 antagonist MPEP","volume":"55","author":"Schroeder","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib357","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0304-3940(02)00306-3","article-title":"Characterization of three novel isoforms of the metabotrobic glutamate receptor 7 (GRM7)","volume":"326","author":"Schulz","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib358","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1021\/jm070400y","article-title":"l-(+)-2-Amino-4-thiophosphonobutyric acid (l-thioAP4), a new potent agonist of group III metabotropic glutamate receptors: increased distal acidity affords enhanced potency","volume":"50","author":"Selvam","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib359","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.neuropharm.2006.05.004","article-title":"Analgesic effects of mGlu1 and mGlu5 receptor antagonists in the rat formalin test","volume":"51","author":"Sevostianova","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib360","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1523\/JNEUROSCI.3696-09.2010","article-title":"Dysregulation of mTOR signaling in fragile X syndrome","volume":"30","author":"Sharma","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib361","doi-asserted-by":"crossref","first-page":"6088","DOI":"10.1523\/JNEUROSCI.0132-09.2009","article-title":"Transient receptor potential-like channel mediates synaptic transmission in rod bipolar cells","volume":"29","author":"Shen","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib362","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/cne.903220110","article-title":"Distribution of the mRNA for a metabotropic glutamate receptor (mGluR1) in the central nervous system: an in situ hybridization study in adult and developing rat","volume":"322","author":"Shigemoto","year":"1992","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib363","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1755-148X.2009.00648.x","article-title":"AKT2 is a downstream target of metabotropic glutamate receptor 1 (Grm1)","volume":"23","author":"Shin","year":"2010","journal-title":"Pigment Cell Melanoma Res."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib364","first-page":"43","article-title":"Excitatory amino acids: physiological and pharmacological probes for neuroscience research","volume":"53","author":"Shinozaki","year":"1993","journal-title":"Acta Neurobiol. Exp. (Wars)"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib365","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1056\/NEJM200001063420104","article-title":"Paraneoplastic cerebellar ataxia due to autoantibodies against a glutamate receptor","volume":"342","author":"Sillevis Smitt","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib366","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/npp.2009.201","article-title":"Repetitive self-grooming behavior in the BTBR mouse model of autism is blocked by the mGluR5 antagonist MPEP","volume":"35","author":"Silverman","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib367","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/317717a0","article-title":"Glutamate stimulates inositol phosphate formation in striatal neurones","volume":"317","author":"Sladeczek","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib368","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3171\/jns.2005.102.2.0216","article-title":"Improvement of bilateral motor functions in patients with Parkinson disease through the unilateral intraputaminal infusion of glial cell line-derived neurotrophic factor","volume":"102","author":"Slevin","year":"2005","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib369","first-page":"555","article-title":"GABA(B) and group I metabotropic glutamate receptors in the striatopallidal complex in primates","volume":"196","author":"Smith","year":"2000","journal-title":"J.\u00a0Anat."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib370","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ejphar.2004.03.055","article-title":"Effects of mGlu1 and mGlu5 metabotropic glutamate antagonists to reverse morphine tolerance in mice","volume":"492","author":"Smith","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib371","doi-asserted-by":"crossref","first-page":"6218","DOI":"10.1523\/JNEUROSCI.20-16-06218.2000","article-title":"Modulation of absence seizures by the GABA(A) receptor: a critical role for metabotropic glutamate receptor 4 (mGluR4)","volume":"20","author":"Snead","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib372","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0028-3908(03)00053-4","article-title":"G protein-coupled receptor kinases regulate metabotropic glutamate receptor 5 function and expression","volume":"44","author":"Sorensen","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib373","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.bmcl.2009.11.001","article-title":"Piperidyl amides as novel, potent and orally active mGlu5 receptor antagonists with anxiolytic-like activity","volume":"20","author":"Spanka","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib374","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0022-3565(24)39029-9","article-title":"Anxiolytic-like effects of the prototypical metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)pyridine in rodents","volume":"295","author":"Spooren","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib375","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.neuropharm.2007.08.002","article-title":"Anxiolytic-like action of MTEP expressed in the conflict drinking Vogel test in rats is serotonin dependent","volume":"53","author":"Stachowicz","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib376","first-page":"856","article-title":"Lack of the antianxiety-like effect of (S)-3,4-DCPG, an mGlu8 receptor agonist, after central administration in rats","volume":"57","author":"Stachowicz","year":"2005","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib377","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/S0028-3908(96)00108-6","article-title":"Human metabotropic glutamate receptor 1: mRNA distribution, chromosome localization and functional expression of two splice variants","volume":"35","author":"Stephan","year":"1996","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib436","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.neuron.2008.05.031","article-title":"Glioma stem cells: a midterm exam","volume":"58","author":"Stiles","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib378","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1085\/jgp.93.1.101","article-title":"B-wave of the electroretinogram. A reflection of ON bipolar cell activity","volume":"93","author":"Stockton","year":"1989","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib379","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0168-8278(02)00384-7","article-title":"Selective blockade of mGlu5 metabotropic glutamate receptors is protective against acetaminophen hepatotoxicity in mice","volume":"38","author":"Storto","year":"2003","journal-title":"J. Hepatol."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib380","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejphar.2004.06.023","article-title":"Mouse hepatocytes lacking mGlu5 metabotropic glutamate receptors are less sensitive to hypoxic damage","volume":"497","author":"Storto","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib381","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/325531a0","article-title":"A new type of glutamate receptor linked to inositol phospholipid metabolism","volume":"325","author":"Sugiyama","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib382","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1124\/jpet.107.124701","article-title":"In vitro pharmacological characterization of novel isoxazolopyridone derivatives as allosteric metabotropic glutamate receptor 7 antagonists","volume":"323","author":"Suzuki","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib383","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.neuroscience.2010.04.016","article-title":"Effect of CFMTI, an allosteric metabotropic glutamate receptor 1 antagonist with antipsychotic activity, on Fos expression in regions of the brain related to schizophrenia","volume":"168","author":"Suzuki","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib384","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrd1630","article-title":"Metabotropic glutamate receptors as novel targets for anxiety and stress disorders","volume":"4","author":"Swanson","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib385","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0896-6273(00)80903-4","article-title":"TASK-1, a two-pore domain K+ channel, is modulated by multiple neurotransmitters in motoneurons","volume":"25","author":"Talley","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib386","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0306-4522(01)00305-0","article-title":"Distribution of metabotropic glutamate receptor mGluR3 in the mouse CNS: differential location relative to pre- and postsynaptic sites","volume":"106","author":"Tamaru","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib387","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0896-6273(92)90118-W","article-title":"A family of metabotropic glutamate receptors","volume":"8","author":"Tanabe","year":"1992","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib388","doi-asserted-by":"crossref","first-page":"38153","DOI":"10.1074\/jbc.M508168200","article-title":"Pias1 interaction and sumoylation of metabotropic glutamate receptor 8","volume":"280","author":"Tang","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib389","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/sj.bjp.0703923","article-title":"Potential anxiolytic- and antidepressant-like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist","volume":"132","author":"Tatarczy\u0144ska","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib390","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/nsmb770","article-title":"Ligand-induced rearrangement of the dimeric metabotropic glutamate receptor 1alpha","volume":"11","author":"Tateyama","year":"2004","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib391","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1073\/pnas.0505925103","article-title":"Dual signaling is differentially activated by different active states of the metabotropic glutamate receptor 1","volume":"103","author":"Tateyama","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib392","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1172\/JCI27341","article-title":"Deficiency in neuronal TGF-beta signaling promotes neurodegeneration and Alzheimer\u2019s pathology","volume":"116","author":"Tesseur","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib393","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0028-3908(00)00169-6","article-title":"(S)-3,4-DCPG, a potent and selective mGlu8a receptor agonist, activates metabotropic glutamate receptors on primary afferent terminals in the neonatal rat spinal cord","volume":"40","author":"Thomas","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib394","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/j.1476-5381.1996.tb15750.x","article-title":"The effects of (RS)-alpha-cyclopropyl-4-phosphonophenylglycine ((RS)-CPPG), a potent and selective metabotropic glutamate receptor antagonist","volume":"119","author":"Toms","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib395","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1073\/pnas.052708599","article-title":"Structural views of the ligand-binding cores of a metabotropic glutamate receptor complexed with an antagonist and both glutamate and Gd3+","volume":"99","author":"Tsuchiya","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib396","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0896-6273(00)80589-9","article-title":"Homer binds a novel proline-rich motif and links group 1 metabotropic glutamate receptors with IP3 receptors","volume":"21","author":"Tu","year":"1998","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib397","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0896-6273(00)80810-7","article-title":"Coupling of mGluR\/Homer and PSD-95 complexes by the Shank family of postsynaptic density proteins","volume":"23","author":"Tu","year":"1999","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib398","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.1093\/hmg\/ddl422","article-title":"Contribution of mGluR and Fmr1 functional pathways to neurite morphogenesis, craniofacial development and fragile X syndrome","volume":"15","author":"Tucker","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib399","doi-asserted-by":"crossref","first-page":"998","DOI":"10.2337\/diabetes.53.4.998","article-title":"Metabotropic glutamate receptor type 4 is involved in autoinhibitory cascade for glucagon secretion by alpha-cells of islet of Langerhans","volume":"53","author":"Uehara","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib400","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0028-3908(99)00095-7","article-title":"Potentiation of NMDA and AMPA responses by the specific mGluR5 agonist CHPG in spinal cord motoneurons","volume":"38","author":"Ugolini","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib401","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/cne.903490409","article-title":"Metabotropic glutamate receptor mGluR1 distribution and ultrastructural localization in hypothalamus","volume":"349","author":"Van den Pol","year":"1994","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib402","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0028-3908(98)00196-8","article-title":"The selective mGlu2\/3 receptor agonist LY354740 attenuates morphine-withdrawal-induced activation of locus coeruleus neurons and behavioral signs of morphine withdrawal","volume":"38","author":"Vandergriff","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib403","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1124\/jpet.104.080481","article-title":"Group III metabotropic glutamate-receptor-mediated modulation of excitatory transmission in rodent substantia nigra pars compacta dopamine neurons","volume":"313","author":"Valenti","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib404","doi-asserted-by":"crossref","first-page":"7218","DOI":"10.1523\/JNEUROSCI.23-18-07218.2003","article-title":"Group III metabotropic glutamate receptor-mediated modulation of the striatopallidal synapse","volume":"23","author":"Valenti","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib405","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0378-1119(00)00547-3","article-title":"Identification of novel alternatively-spliced mRNA isoforms of metabotropic glutamate receptor 6 gene in rat and human retina","volume":"262","author":"Valerio","year":"2001","journal-title":"Gene"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib406","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.ajhg.2009.10.012","article-title":"Mutations in TRPM1 are a common cause of complete congenital stationary night blindness","volume":"85","author":"Van Genderen","year":"2009","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib407","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/1096-9861(20000731)423:3<402::AID-CNE4>3.0.CO;2-E","article-title":"Localization of mGluR6 to dendrites of ON bipolar cells in primate retina","volume":"423","author":"Vardi","year":"2000","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib408","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.pbb.2010.01.010","article-title":"MK-801 produces a deficit in sucrose preference that is reversed by clozapine, d-serine, and the metabotropic glutamate 5 receptor positive allosteric modulator CDPPB: relevance to negative symptoms associated with schizophrenia?","volume":"95","author":"Vardigan","year":"2010","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib409","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2174\/1568007023339300","article-title":"Metabotropic glutamate receptor involvement in models of acute and persistent pain: prospects for the development of novel analgesics","volume":"1","author":"Varney","year":"2002","journal-title":"Curr. Drug Targets CNS Neurol. Disord."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib410","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00213-005-2143-4","article-title":"The antinociceptive and anxiolytic-like effects of the metabotropic glutamate receptor 5 (mGluR5) antagonists, MPEP and MTEP, and the mGluR1 antagonist, LY456236, in rodents: a comparison of efficacy and side-effect profiles","volume":"179","author":"Varty","year":"2005","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib411","doi-asserted-by":"crossref","first-page":"10656","DOI":"10.1523\/JNEUROSCI.19-24-10656.1999","article-title":"Long-term depression of excitatory synaptic transmission in the rat amygdala","volume":"19","author":"Wang","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib412","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1126\/science.1178496","article-title":"Norbin is an endogenous regulator of metabotropic glutamate receptor 5 signaling","volume":"326","author":"Wang","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib413","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.conb.2009.03.011","article-title":"Protein translation in synaptic plasticity: mGluR-LTD, fragile X","volume":"19","author":"Waung","year":"2009","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib414","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1111\/j.1460-9568.2007.05614.x","article-title":"Differential role of mGlu1 and mGlu5 receptors in rat hippocampal slice models of ischemic tolerance","volume":"25","author":"Werner","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib415","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00213-003-1636-2","article-title":"Serotonergic\/glutamatergic interactions: the effects of mGlu2\/3 receptor ligands in rats trained with LSD and PCP as discriminative stimuli","volume":"172","author":"Winter","year":"2004","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib416","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0169-328X(00)00283-7","article-title":"Localization of the human mGluR4 gene within an epilepsy susceptibility locus(1)","volume":"87","author":"Wong","year":"2001","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib417","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1046\/j.1471-4159.1997.69010174.x","article-title":"N-Acetylaspartylglutamate selectively activates mGluR3 receptors in transfected cells","volume":"69","author":"Wroblewska","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib418","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0896-6273(00)80588-7","article-title":"Homer regulates the association of group 1 metabotropic glutamate receptors with multivalent complexes of homer-related, synaptic proteins","volume":"21","author":"Xiao","year":"1998","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib419","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.neuron.2006.12.020","article-title":"Calpain-mediated mGluR1alpha truncation: a key step in excitotoxicity","volume":"53","author":"Xu","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib420","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.neuroscience.2009.07.060","article-title":"Metabotropic glutamate mGluR5 receptor blockade opposes abnormal involuntary movements and the increases in glutamic acid decarboxylase mRNA levels induced by l-DOPA in striatal neurons of 6-hydroxydopamine-lesioned rats","volume":"163","author":"Yamamoto","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib421","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.neuropharm.2005.06.004","article-title":"Suppression of two major fragile X syndrome mouse model phenotypes by the mGluR5 antagonist MPEP","volume":"49","author":"Yan","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib422","doi-asserted-by":"crossref","first-page":"6388","DOI":"10.1523\/JNEUROSCI.22-15-06388.2002","article-title":"Peripheral group II metabotropic glutamate receptors (mGluR2\/3) regulate prostaglandin E2-mediated sensitization of capsaicin responses and thermal nociception","volume":"22","author":"Yang","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib423","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1158\/1078-0432.CCR-08-3303","article-title":"A phase 0 trial of riluzole in patients with resectable stage III and IV melanoma","volume":"15","author":"Yip","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib424","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1126\/science.273.5275.645","article-title":"Impairment of hippocampal mossy fiber LTD in mice lacking mGluR2","volume":"273","author":"Yokoi","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib425","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.bbrc.2004.01.073","article-title":"Increased cell proliferation in the adult mouse hippocampus following chronic administration of group II metabotropic glutamate receptor antagonist, MGS0039","volume":"315","author":"Yoshimizu","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib426","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00213-006-0390-7","article-title":"An mGluR2\/3 antagonist, MGS0039, exerts antidepressant and anxiolytic effects in behavioral models in rats","volume":"186","author":"Yoshimizu","year":"2006","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib427","doi-asserted-by":"crossref","first-page":"4328","DOI":"10.1167\/iovs.05-0526","article-title":"Mutations in GRM6 cause autosomal recessive congenital stationary night blindness with a distinctive scotopic 15-Hz flicker electroretinogram","volume":"46","author":"Zeitz","year":"2005","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib428","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/j.1365-2982.2010.01484.x","article-title":"Efficacy, tolerability and pharmacokinetics of a modified release formulation of ADX10059, a negative allosteric modulator of metabotropic glutamate receptor 5: an esophageal pH-impedance study in healthy subjects","volume":"22","author":"Zerbib","year":"2010","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib429","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/sj.npp.1300013","article-title":"Group II metabotropic glutamate receptor modulation of DOI-induced c-fos mRNA and excitatory responses in the cerebral cortex","volume":"28","author":"Zhai","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2010.10.022_bib430","doi-asserted-by":"crossref","first-page":"10561","DOI":"10.1523\/JNEUROSCI.2666-08.2008","article-title":"The tyrosine phosphatase STEP mediates AMPA receptor endocytosis after metabotropic glutamate receptor stimulation","volume":"28","author":"Zhang","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib431","doi-asserted-by":"crossref","first-page":"8604","DOI":"10.1523\/JNEUROSCI.0628-08.2008","article-title":"Knock-in mice lacking the PDZ-ligand motif of mGluR7a show impaired PKC-dependent autoinhibition of glutamate release, spatial working memory deficits, and increased susceptibility to pentylenetetrazol","volume":"28","author":"Zhang","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib432","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1167\/iovs.09-4163","article-title":"RGS7 and -11 complexes accelerate the ON-bipolar cell light response","volume":"51","author":"Zhang","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.neuropharm.2010.10.022_bib433","doi-asserted-by":"crossref","first-page":"8853","DOI":"10.1523\/JNEUROSCI.2978-04.2004","article-title":"Recovery from polyglutamine-induced neurodegeneration in conditional SCA1 transgenic mice","volume":"24","author":"Zu","year":"2004","journal-title":"J. Neurosci."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390810002923?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390810002923?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T06:42:44Z","timestamp":1758436964000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390810002923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":435,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0028390810002923"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2010.10.022","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabotropic glutamate receptors: From the workbench to the bedside","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2010.10.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}